NBank Capital
100% subsidiary of NBank – Investitions- und Förderbank Niedersachsen
Also known as NBank Capital Beteiligungsgesellschaft mbH, NBank Capital GmbH, NCapital
Hannover-based equity arm (100%) of Lower Saxony's development bank NBank; open and silent participations in Lower Saxony start-ups and SMEs, about 80 portfolio companies.
Equity subsidiary of NBank (Investitions- und Förderbank Niedersachsen), Hannover; not to be confused with NRW.BANK or with N-Bank-branded entities outside Lower Saxony.
- HEADQUARTERS
- Hannover, Germany
- FOUNDED
- —
- AUM
- —
- OUTSIDE CAPITAL
- No — own capital only
- TEAM LISTED
- 15 people
Focus
- STAGES
- SeedSeries AGrowthBuyout
- SECTORS
- Industrial & ManufacturingSoftware & SaaSHealthTechBiotech & Life SciencesClimate & EnergyConsumer & E-commerceMobility & LogisticsArtificial Intelligence
- ASSET MIX
- Direct investmentsVenture capital
- GEOGRAPHY
- Germany
Overview
NBank Capital Beteiligungsgesellschaft mbH is a wholly owned subsidiary of NBank, the Investitions- und Förderbank of the Land Niedersachsen, and is based in Hannover. It provides open and silent participations to start-ups and small and medium-sized companies in Lower Saxony, from seed financing (NSeed) to growth, MBO/MBI and succession financing (NBeteiligung, NMittelstand, NTransformation Kfz-Zulieferer), with no sector focus. Its programmes deploy funds of the Land Niedersachsen and the European Regional Development Fund (EFRE). In September 2025 it described its portfolio as about 80 companies.
Investment thesis
Equity and quasi-equity for companies in Lower Saxony: seed capital for start-ups up to about five years old with innovative products (NSeed), open or silent growth participations for SMEs with 7–10 year terms (NBeteiligung), and participations of up to €5m for Mittelstand companies and automotive suppliers in transformation (NMittelstand, NTransformation); no sector focus.
PORTFOLIO (61)
- 4PL Intermodal GmbHsince 2018
- Abacus Maschinenbau GmbHsince 2017
- ALL ABOUT MIDLIFE GMBHsince 2026
- angeln-in UG (Haftungsbeschränkt)since 2021
- Angiolutions GmbHsince 2020
- ArgillaTherm GmbHsince 2017
- B&S Media GmbH alias cruisewatch.comsince 2019
- Biomethan Soltau GmbHsince 2019
- BlockAxssince 2021 · Exited (2024)
- Buses4Future GmbHsince 2021
- Corat Therapeutics GmbHsince 2020
- EEO Tech GmbHsince 2021
- Emma GmbHsince 2021
- ERASON GmbHsince 2021
- exabotix finance GmbHsince 2018
- FiSens GmbHsince 2018
- FLEXBIO Technologie GmbHsince 2019
- Flexxter GmbHsince 2020
- G-Metrics GmbHsince 2019
- Goodright GmbHsince 2022
- HANOMAG Aluminium Solution GmbHsince 2021
- HepaNet GmbHsince 2019
- Herodikos GmbHsince 2025
- HeyDo Apps GmbHsince 2019 · Exited (2026)
- heyParentssince 2025
- HINAMIC GmbHsince 2021
- Horando Deutschland GmbHsince 2019
- IDENTYTEC GmbH & Co.KGsince 2019
- J. Schwarzer GmbH & Co. Service KGsince 2016
- Lambus GmbHsince 2022 · Exited (2025)
- LBR Manufacturing GmbHsince 2025
- Lilian Labs GmbHsince 2017
- Linder GmbHsince 2018
- Lomalab Technologies GmbHsince 2022
- mediaTest digital GmbHsince 2016
- NautilusLog GmbHsince 2020
- NEXSD AUTOMOTIVE INNOVATIONS GmbHsince 2023
- nya nordiska innovation GmbHsince 2019
- Pan Acoustics GmbHsince 2019 · Exited (2024)
- Phaeosynt GmbHsince 2025
- Picum MT GmbHsince 2021
- PlantBase GmbHsince 2020 · Exited (2022)
- Proflexis GmbHsince 2021
- reamotion GmbHsince 2019
- Reha Klinik Sonnenhof Bad Iburg GmbH & Co. KGsince 2021
- Robot Food Technologies Germany GmbHsince 2016
- Sascotec Horsepower GmbHsince 2024
- Showerplus Entwicklungs- und Vertriebsgesellschaft mbHsince 2021
- SKYSEED GmbHsince 2025
- smapOne AGsince 2016 · Exited (2021)
- SugarShape GmbHsince 2017
- Sustainable Manufacturing GmbH (Recozy)since 2023
- VANEVO GmbHsince 2020
- verlingo GmbHsince 2019 · Exited (2022)
- VisioLab GmbHsince 2021
- BiowegBiotech & Life Sciences · since 2025
- Allogenetics GmbHBiotech & Life Sciences · since 2024
- Fehrmann MaterialsX GmbHArtificial Intelligence · since 2026
- Digity GmbHsince 2024
- Seedforward GmbHsince 2024
- Pacta AISoftware & SaaS · Acquired by DiliTrust (2025)
People
- Christoph SiegfriedManaging Director (Geschäftsführer) · source
- Simon KöhlerManaging Director (Geschäftsführer) · source
- Ralf BorchersManaging Director (Geschäftsführer) · source
- Volker EbelingInvestment Manager (Beteiligungsmanager) · source
- Susanne HauckInvestment Manager and Mikromezzaninfonds (Beteiligungsmanagerin) · source
- Stefan LenzInvestment Manager (Beteiligungsmanager) · source
- Ulrich LohmannInvestment Manager (Beteiligungsmanager) · source
- Marc LöfflerInvestment Manager (Beteiligungsmanager) · source
- Jan MackieInvestment Services (Beteiligungsservice) · source
- Alina Meyer-WarneckeInvestment Manager (Beteiligungsmanagerin) · source
- Thomas MüllerInvestment Manager (Beteiligungsmanager) · source
- Isabel SieversInvestment Manager (Beteiligungsmanagerin) · source
- Viktoria VorwachsInvestment Manager (Beteiligungsmanagerin) · source
- Sina Jüttner-SindermannInvestment Manager (Beteiligungsmanagerin) · source
- Oliver HackerInvestment Manager (Beteiligungsmanager) · source
Links
Frequently asked questions
NBank Capital is a government-backed fund based in Hannover, Germany.
Yes. NBank Capital invests its own capital in private companies.
NBank Capital invests at Seed, Series A, Growth and Buyout stages in Industrial & Manufacturing, Software & SaaS, HealthTech, Biotech & Life Sciences, Climate & Energy, Consumer & E-commerce, Mobility & Logistics and Artificial Intelligence.
NBank Capital's stated ticket size is Up to €5M.
Key people at NBank Capital include Christoph Siegfried (Managing Director (Geschäftsführer)), Simon Köhler (Managing Director (Geschäftsführer)), Ralf Borchers (Managing Director (Geschäftsführer)) and Volker Ebeling (Investment Manager (Beteiligungsmanager)).
NBank Capital's investments include 4PL Intermodal GmbH, Abacus Maschinenbau GmbH, ALL ABOUT MIDLIFE GMBH, angeln-in UG (Haftungsbeschränkt), Angiolutions GmbH, ArgillaTherm GmbH, B&S Media GmbH alias cruisewatch.com and Biomethan Soltau GmbH, among others.
The most recent publicly reported investment by NBank Capital is Allogenetics GmbH (Pre-Series A), announced in Sep 2026.
NBank Capital states that it accepts submissions through its official contact page.
No. NBank Capital invests its own capital and does not raise money from outside investors.